Immuron (IMRN) Other Accumulated Expenses (2016 - 2025)
Immuron (IMRN) posted quarterly Other Accumulated Expenses of $452.72 for Q3 2025, up 11.63% year-over-year from $405.56 in Q3 2024, and down 98.4% quarter-over-quarter from $28239.2 in Q4 2024.
Immuron (IMRN) Other Accumulated Expenses (2016 - 2025) Analysis & Trends
Immuron's Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $452.72 for Q3 2025.
- In Q3 2025, Other Accumulated Expenses rose 11.63% year-over-year to $452.72; the TTM figure through Sep 2025 stood at $452.72 (up 11.63% YoY), while the FY2025 annual figure was $452.72, up 11.63% from the prior year.
- Other Accumulated Expenses for Q3 2025 stood at $452.72, down from $28239.2 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $38767.0 in Q2 2023, with the low at $157.85 in Q2 2021.
- The 5-year median for Other Accumulated Expenses is $15004.9 (2021), against an average of $14042.2.
- Peak annual rise in Other Accumulated Expenses reached 15644.58% in 2023, while the deepest fall reached 98.86% in 2023.
- Immuron's Other Accumulated Expenses stood at $15004.9 in 2021, then jumped by 50.52% to $22585.8 in 2022, then slumped by 98.86% to $258.13 in 2023, then surged by 10839.86% to $28239.2 in 2024, then tumbled by 98.4% to $452.72 in 2025.
- Business Quant data shows IMRN's Other Accumulated Expenses at $452.72 in Q3 2025, $28239.2 in Q4 2024, and $405.56 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 452.72 |
| Dec 31, 2024 | 28,239.15 |
| Sep 9, 2024 | 405.56 |
| Jun 30, 2024 | 26,727.40 |
| Dec 31, 2023 | 258.13 |
| Sep 28, 2023 | 25,410.98 |
| Aug 30, 2023 | 387.67 |
| Jun 30, 2023 | 38,767.00 |
| Dec 31, 2022 | 22,585.78 |
| Aug 31, 2022 | 23,905.86 |
| Jun 30, 2022 | 246.22 |
| Dec 31, 2021 | 15,004.91 |
| Jun 30, 2021 | 157.85 |
| Dec 31, 2020 | 415.45 |
| Sep 1, 2020 | 42,176.00 |
| Dec 31, 2019 | 421.76 |
| Jun 30, 2017 | 126,478.28 |
| Dec 31, 2016 | 56,505.38 |